메뉴 건너뛰기




Volumn 7, Issue 1, 2009, Pages 26-28

Regulation of drug pricing in Australia, England, and New Zealand

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG COST; DRUG FORMULARY; DRUG LEGISLATION; DRUG MARKETING; GOVERNMENT REGULATION; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HUMAN; LIFE EXPECTANCY; NEW ZEALAND; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; QUALITY ADJUSTED LIFE YEAR; REFERENCE VALUE; UNITED KINGDOM; UNITED STATES; ECONOMICS; INTERVIEW; LEGAL ASPECT;

EID: 63449107209     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (1)
  • 1
    • 42149128313 scopus 로고    scopus 로고
    • Paying for costly pharmaceuticals: Regulation of new drugs in Australia, England, and New Zealand
    • Raftery J. Paying for costly pharmaceuticals: regulation of new drugs in Australia, England, and New Zealand. MJA. 2008;188:26-28.
    • (2008) MJA , vol.188 , pp. 26-28
    • Raftery, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.